KIMS Q1 FY27 Profit Plunges 56% as Expansion Costs Bite Into Surging Revenue
Krishna Institute of Medical Sciences posted a 35% revenue surge driven by patient volumes, but profit fell by more than half as new hospitals and high debt costs squeezed margins.
KIMS Hospitals reported a sharp divergence in Q1 FY27: revenue grew 35.3% year-on-year, yet net profit collapsed by 56%. The gap highlights the near-term cost of aggressive expansion, with new units and elevated finance expenses pressuring profitability.
For Krishna Institute of Medical Sciences, the first quarter was a story of two speeds. The hospital chain's revenue engine roared ahead, fueled by a nationwide expansion that added hundreds of beds. Yet, the cost of that very growth slammed the brakes on profitability, turning a top-line triumph into a bottom-line squeeze.
The numbers lay out the tension clearly. Revenue from operations jumped 35.3% year-on-year to ₹1,179.5 crore, a sequential rise of 9.8%. However, profit after tax (PAT) plunged 56% to ₹37.4 crore, even as it improved 13% from the previous quarter. The net profit margin contracted sharply by 660 basis points to just 3.2%.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 1,179.5YoY +35% | 1,074.6 | 871.6 |
| Profit (₹ Cr) | 37.4YoY -56% | 33.1 | 85.0 |
| Net Profit Margin (%) | 3.2YoY -67% | 3.1 | 9.8 |
The Growth Engine Is Firing
The revenue surge was broad-based. According to the earnings call summary on Quartermark, inpatient volumes rose 26.6% and outpatient visits jumped 28.5% year-on-year. Average revenue per occupied bed (ARPOB) also grew 9.7%, showing growth came from both more patients and better realizations. This was powered by the rapid ramp-up of new facilities like the Mahadevapura unit in Bengaluru, which achieved EBITDA breakeven in under seven months, and the newly launched Palakkad hospital in Kerala.
Why Profit Couldn't Keep Pace
This expansion came at a steep price. New hospitals in Karnataka, Maharashtra, and Kerala are still in their investment phase, dragging down consolidated margins. Reports from InvestorStack and Inve.money note pre-operative costs of ₹1.5-2 crore per month at the new Kondapur facility, while the old Kondapur unit continues as a cost drag for another six months. More critically, finance costs surged 155% year-on-year to ₹83.4 crore, as per Faxioms.com, eating deeply into profits before a major debt repayment.
A Turning Point in Q2?
The quarter also set the stage for potential relief. The company raised ₹1,500 crore through a Qualified Institutional Placement (QIP) and used ₹1,100 crore to repay debt, bringing it down to approximately ₹2,400 crore. Management, cited by Yahoo Finance, expects the full benefit of lower interest costs to be visible from the second quarter onwards. The focus now shifts to completing key insurance empanelments for new assets and stabilizing recently commissioned hospitals.
Key Points
- Revenue grew 35.3% YoY to ₹1,179.5 crore, driven by a 26.6% rise in inpatient volumes and a 28.5% jump in outpatient visits.
- Net profit fell 56% YoY to ₹37.4 crore, as margin was squeezed by ramp-up costs at new hospitals and a 155% surge in finance costs.
- A ₹1,500 crore QIP facilitated a ₹1,100 crore debt repayment, with interest cost savings expected to aid profitability from Q2 FY27.
- Management is targeting EBITDA breakeven for the Bengaluru cluster in FY27 and sees the new Kondapur hospital reaching ₹1,200 crore annual revenue potential in 4-5 years.
Hexa Perspective
The quarter confirms KIMS is deep in an investment cycle where revenue growth and profit growth have decoupled. The 660-basis-point margin contraction is the direct cost of building future capacity. The path to reconciliation hinges on two factors: the speed at which new units like Electronic City reach breakeven, and the durability of patient volume growth to absorb the added beds.
The recent deleveraging is a crucial step, turning a persistent financial drag into a potential tailwind. Investors are essentially funding today's losses for tomorrow's market share, betting that the company's regional clustering strategy will eventually deliver the operating leverage its mature Telangana assets already show.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.